Chinese medical device maker Basecare, which specializes in manufacturing devices for embryonic pre-implantation genetic screening, has raised a RMB100 million (US$14 million) series B round from unnamed investors.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?